This study investigates the safety and efficacy of a treatment for unresectable locally advanced pancreatic cancer. It focuses on the use of an investigational medication to see how it affects the condition.
The study evaluates the safety of the investigational medication, as well as its distribution in the body and effects on cancer-related symptoms such as pain. Researchers will also look at changes in tumor markers.
- Who can participate: Adults aged 18 to 80 years with unresectable locally advanced pancreatic cancer can participate. Key factors include a good performance status and adequate organ function.
- Study details: Participants will receive an investigational medication and will be monitored for safety and efficacy. A placebo may be used in the study.
How understandable was the trial content above?
Hard to understand
Easy to understand